S-Biomedic
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
1
Ending by 2030
Oct 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 13, 2027The maintenance fee for Method for producing pluripotent stem cell-derived spherical neural mass having suppressed teratoma formation (US 11,898,164) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,492,149 | Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells In force · From the USPTO record | In force | From the USPTO record | |
| US 8,669,075 | Method for the Immobilization of Biologically Active Polypeptides by Using Maltose Binding Protein In force · High confidence | In force | High confidence | |
| US 8,551,783 | Efficient and Universal Method for Neural Differentiation of Human Pluripotent Stem Cells In force · High confidence | In force | High confidence | |
| US 9,644,183 | Method for Differentiation of Stem Cells into Vascular Cells and the Induction of Angiogenesis Using the Same In force · High confidence | In force | High confidence | |
| US 10,725,043 | Three-Dimensional Fibroblast Aggregate and in Vitro 3D Skin Dermis Model Comprising Same In force · High confidence | In force | High confidence | |
| US 10,774,305 | Methods and Compositions for Changing the Composition of the Skin Microbiome Using Complex Mixtures of Bacterial Strains In force · High confidence | In force | High confidence | |
| US 11,987,788 | Methods and Compositions for Changing the Composition of the Skin Microbiome Using Complex Mixtures of Bacterial Strains In force · Medium confidence | In force | Medium confidence | |
| US 10,688,135 | Composition for treating ischemic diseases or neuroinflammatory diseases, comprising secretome of neural precursor cells as active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 11,365,396 | In vitro fibrosis model, preparing method therefor, and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,541,081 | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 4 abandoned · 2 no status recorded